FHIR Cross-Version Extensions package for FHIR R5 from FHIR R4 - Version 0.0.1-snapshot-2. See the Directory of published versions
| Official URL: http://hl7.org/fhir/4.0/ValueSet/R4-v3-substanceAdminSubstitution-for-R5 | Version: 0.0.1-snapshot-2 | |||
| Standards status: Informative | Maturity Level: 0 | Responsible: HL7 International / Terminology Infrastructure | Computable Name: R4_v3_substanceAdminSubstitution_for_R5 | |
| This cross-version ValueSet represents concepts from http://terminology.hl7.org/ValueSet/v3-substanceAdminSubstitution | 2018-08-12 for use in FHIR R5. Concepts not present here have direct equivalent mappings crossing all versions from R4 to R5. |
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution version 2018-08-12| Code | Display | Definition |
| BC | brand composition | Substitution occurred or is permitted between equivalent Brands but not Generics *Examples:* * Zestril for Prinivil * Coumadin for Jantoven |
| G | generic composition | Substitution occurred or is permitted between equivalent Generics but not Brands *Examples:* * Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp) |
| EC | equivalent composition | Substitution occurred or is permitted with another product that is a: * pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester * pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration *Examples:* * *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate * *Pharmaceutical equivalent:* Lisonpril for Zestril |
| TB | therapeutic brand | Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > *Examples:* * Zantac for Tagamet |
| TG | therapeutic generic | Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > *Examples:* * Ranitidine for cimetidine |
| TE | therapeutic alternative | Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. *Examples:* * ranitidine for Tagamet |
| E | equivalent | Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product. |
| F | formulary | This substitution was performed or is permitted based on formulary guidelines. |
| N | none | No substitution occurred or is permitted. |
This value set expansion contains 9 concepts.
| Code | System | Display | Definition |
| BC | http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution | brand composition | Substitution occurred or is permitted between equivalent Brands but not Generics Examples:
|
| G | http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution | generic composition | Substitution occurred or is permitted between equivalent Generics but not Brands Examples:
|
| EC | http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution | equivalent composition | Substitution occurred or is permitted with another product that is a:
Examples:
|
| TB | http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution | therapeutic brand | Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics Examples:
|
| TG | http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution | therapeutic generic | Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands Examples:
|
| TE | http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution | therapeutic alternative | Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples:
|
| E | http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution | equivalent | Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product. |
| F | http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution | formulary | This substitution was performed or is permitted based on formulary guidelines. |
| N | http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution | none | No substitution occurred or is permitted. |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |